Cannabis stocks got a boost this week after the US Food and Drug Administration announced it would expedite creating a regulatory framework for CBD. CBD is the non-psychoactive ingredient in cannabis, which allegedly has wellness properties, and can treat a range of various conditions, including pain management. The FDA and CBD Regulation Is All Boxed […]

The post Cannabis Stocks Blaze as FDA Expedites Landmark CBD Rules appeared first on CCN Markets